Search Results

Filter
  • 1-10 of  840 results for ""Artemether, Lumefantrine Drug Combination""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Increasing Prevalence of Artemisinin-Resistant HRP2-Negative Malaria in Eritrea.

  • Authors : Mihreteab S; From the National Malaria Control Program (S.M.) and the Communicable Diseases Control Division (A.B.), Ministry of Health, and the World Health Organization (A.Z.K.) - both in Asmara, Eritrea; the Malaria Genetic and Resistance Unit, INSERM Unité 1201 (L.P., N.P., E.L., D.M.), the Malaria Parasite Biology and Vaccines Unit (L.P., E.L. D.M.), the Bioinformatics and Biostatistics Hub (P.C., A.C.), and the Biomics Platform, Center for Technological Resources and Research (L.M.), Institut Pasteur, Université Paris Cité, and Collège Ecole Doctorale Complexité du Vivant, Sorbonne Université (L.P.), Paris, and the Institute of Parasitology and Tropical Diseases, Dynamics of Host-Pathogen Interactions, Université de Strasbourg (C.D.-L., D.M.), and the Laboratory of Parasitology and Medical Mycology, Centre Hospitalier Universitaire Strasbourg (D.M.), Strasbourg - all in France

Subjects: Antimalarials*/Antimalarials*/Antimalarials*/pharmacology ; Antimalarials*/Antimalarials*/Antimalarials*/therapeutic use ; Artemether, Lumefantrine Drug Combination*/Artemether, Lumefantrine Drug Combination*/Artemether, Lumefantrine Drug Combination*/pharmacology

  • Source: The New England journal of medicine [N Engl J Med] 2023 Sep 28; Vol. 389 (13), pp. 1191-1202.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Trends of Plasmodium falciparum molecular markers associated with resistance to artemisinins and reduced susceptibility to lumefantrine in Mainland Tanzania from 2016 to 2021.

  • Authors : Bakari C; National Institute for Medical Research, Dar Es Salaam, Tanzania.; Swiss Tropical and Public Health Institute, Basel, Switzerland.

Subjects: Antimalarials*/Antimalarials*/Antimalarials*/pharmacology ; Antimalarials*/Antimalarials*/Antimalarials*/therapeutic use ; Artemisinins*/Artemisinins*/Artemisinins*/pharmacology

  • Source: Malaria journal [Malar J] 2024 Mar 09; Vol. 23 (1), pp. 71. Date of Electronic Publication: 2024 Mar 09.Publisher: BioMed Central Country of Publication: England NLM ID: 101139802 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2875

Record details

×
Academic Journal

Treatment Failure in a UK Malaria Patient Harboring Genetically Variant Plasmodium falciparum From Uganda With Reduced In Vitro Susceptibility to Artemisinin and Lumefantrine.

  • Authors : van Schalkwyk DA; Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.; Pratt S

Subjects: Antimalarials*/Antimalarials*/Antimalarials*/pharmacology ; Antimalarials*/Antimalarials*/Antimalarials*/therapeutic use ; Artemisinins*/Artemisinins*/Artemisinins*/pharmacology

  • Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Feb 17; Vol. 78 (2), pp. 445-452.Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Efficacy of 3-day low dose quinine plus clindamycin versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children (CLINDAQUINE): an open-label randomized trial.

  • Authors : Obonyo CO; Centre for Global Health Research, Kenya Medical Research Institute, P.O. Box 1578, Kisumu, Kenya. .; Juma EA

Subjects: Artemether, Lumefantrine Drug Combination/Artemether, Lumefantrine Drug Combination/Artemether, Lumefantrine Drug Combination/*therapeutic use ; Clindamycin/Clindamycin/Clindamycin/*therapeutic use ; Malaria, Falciparum/Malaria, Falciparum/Malaria, Falciparum/*drug therapy

  • Source: Malaria journal [Malar J] 2022 Feb 02; Vol. 21 (1), pp. 30. Date of Electronic Publication: 2022 Feb 02.Publisher: BioMed Central Country of Publication: England NLM ID: 101139802 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2875

Record details

×
Academic Journal

Novel transdermal bioadhesive surfactant-based system for release and solubility improvement of antimalarial drugs artemether-lumefantrine.

  • Authors : Volpe-Zanutto F; Graduate School of Bioscience and Technology of Bioactive Products, Biology Institute, University at Campinas, Campinas, Sao Paulo, Brazil.; School of Pharmacy, Queen's University Belfast, Belfast, United Kingdom.

Subjects: Antimalarials*/Antimalarials*/Antimalarials*/administration & dosage ; Antimalarials*/Antimalarials*/Antimalarials*/chemistry ; Antimalarials*/Antimalarials*/Antimalarials*/pharmacokinetics

  • Source: Biomedical materials (Bristol, England) [Biomed Mater] 2021 Oct 04; Vol. 16 (6). Date of Electronic Publication: 2021 Oct 04.Publisher: Institute of Physics Pub Country of Publication: England NLM ID: 101285195 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Safety and efficacy of pyronaridine-artesunate paediatric granules in the treatment of uncomplicated malaria in children: insights from randomized clinical trials and a real-world study.

  • Authors : Ramharter M; Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.; Department of Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Subjects: Antimalarials*/Antimalarials*/Antimalarials*/adverse effects ; Artemisinins*/Artemisinins*/Artemisinins*/adverse effects ; Malaria, Falciparum*/Malaria, Falciparum*/Malaria, Falciparum*/drug therapy

  • Source: Malaria journal [Malar J] 2024 Feb 28; Vol. 23 (1), pp. 61. Date of Electronic Publication: 2024 Feb 28.Publisher: BioMed Central Country of Publication: England NLM ID: 101139802 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2875

Record details

×
Academic Journal

Forensic investigation of falsified antimalarials using isotope ratio mass spectrometry: a pilot investigation.

  • Authors : Newton PN; Lao-Oxford-Mahosot Hospital-Wellcome Research Unit (LOMWRU), Microbiology Laboratory, Mahosot Hospital, Vientiane, Lao PDR. .; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK. .

Subjects: Antimalarials*/Antimalarials*/Antimalarials*/therapeutic use; Artesunate ; Pilot Projects

  • Source: Scientific reports [Sci Rep] 2024 Feb 18; Vol. 14 (1), pp. 3995. Date of Electronic Publication: 2024 Feb 18.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Have You Heard the News? Artemether-lumefantrine is Now Recommended for ALL Uncomplicated Malaria in the United States, Including in Pregnancy.

  • Authors : Castro L; Malaria Branch, Division of Parasitic Diseases and Malaria, Global Health Center, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; Epidemic Intelligence Service, Center for Surveillance, Epidemiology and Laboratory Services, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Subjects: Antimalarials*/Antimalarials*/Antimalarials*/therapeutic use ; Malaria*/Malaria*/Malaria*/drug therapy ; Malaria*/Malaria*/Malaria*/epidemiology

  • Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Feb 17; Vol. 78 (2), pp. 245-247.Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Effectiveness of artemether-lumefantrine for treating uncomplicated malaria in low- and high-transmission areas of Ghana.

  • Authors : Mawuli MA; West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), College of Basic and Applied Sciences, University of Ghana, Legon, Accra, Ghana. .; Department of Pathology, University of Ghana Medical School, College of Health Sciences, University of Ghana, Korle-Bu, Accra, Ghana. .

Subjects: Antimalarials*/Antimalarials*/Antimalarials*/therapeutic use ; Artemisinins*/Artemisinins*/Artemisinins*/therapeutic use ; Malaria, Falciparum*/Malaria, Falciparum*/Malaria, Falciparum*/drug therapy

  • Source: Malaria journal [Malar J] 2024 Feb 05; Vol. 23 (1), pp. 40. Date of Electronic Publication: 2024 Feb 05.Publisher: BioMed Central Country of Publication: England NLM ID: 101139802 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2875

Record details

×
Academic Journal

Nanoliposomes Embedded Nanocochleates for Codelivery of Artemether and Lumefantrine: An In Vitro and In Vivo Study.

  • Authors : Mathure D; Department of Pharmaceutics, Bharati Vidyapeeth's Poona College of Pharmacy, Bharati Vidyapeeth Deemed University, Pune, India.; Sonawane P

Subjects: Antimalarials*/Antimalarials*/Antimalarials*/therapeutic use ; Malaria*/Malaria*/Malaria*/drug therapy ; Malaria*/Malaria*/Malaria*/parasitology

  • Source: Assay and drug development technologies [Assay Drug Dev Technol] 2024 Feb-Mar; Vol. 22 (2), pp. 63-72. Date of Electronic Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101151468 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
  • 1-10 of  840 results for ""Artemether, Lumefantrine Drug Combination""